Work

A Phase 1 Study Evaluating ABT-414 with Temozolomide (TMZ) or Concurrent Radiotherapy (RT) and TMZ in Glioblastoma (GBM) (S43.006)

Year: 2015

Type: article

Study design: Clinical Trial

Source: Neurology

DOI: 10.1212/wnl.84.14_supplement.s43.006

Authors: Andrew Lassman, Hui Gan, Lisa Fichtel, Ryan Merrell, Martin Van Den Bent, Priya Kumthekar, Andrew Scott, Michelle Pedersen, Erica Gomez, JuDee Fischer, William Ames, Hao Xiong, Ho-Jin Lee, Wijith Munasinghe, Lisa Roberts-Rapp, Peter Ansell, Kyle Holen, David Reardon

Institutions: Columbia University Irving Medical Center, Columbia University, Ludwig Cancer Research, Ludwig Cancer Research, Endeavor Health, Erasmus MC, Erasmus MC Cancer Institute, Northwestern University, AbbVie (United States), Center for Neuro-Oncology

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1882963942

FWCI: 0.328

Cites:

Cited by: 5

Related to: 10